Role: Associate Creative Director | Copy
POMALYST is indicated for multiple myeloma when the disease relapses and becomes refractory to current treatment. POMALYST helps patients continue their battle against this non-curable blood cancer.
I wrote the POMALYST patient site that is now live at: https://pomalyst.com
